Pluristem Therapeutics Inc (PSTI)

[Scott999]

And look at that...they partner with JCR in Japan and they get a product approved. One we are just starting to get into. Not sure if it's the same, but they're both GvHD. Maybe they should have worked quicker on partnering in Japan. Trial would be done and would have had a marketable product by now. It's been 2 freaking years!!! But let's hold out because we can do more raises. Great job twins!!! We should now focus more on products that are approved by someone else.

JCR Pharmaceuticals Co. Ltd has been granted an exclusive right in Japan to Mesoblast’s technology for use in conjunction with the treatment for hematologic malignancies using hematopoietic stem cell transplants derived from peripheral blood, cord blood or bone marrow. JCR has received Japanese Government regulatory approval for its mesenchymal stem cell-based product for children and adults with acute graft versus host disease. TEMCELL® HS Inj. is the first allogeneic cell-based product to receive full approval in Japan